Highlights
NASDAQ: HALO       Halozyme Therapeutic
Last Price Today's Change   Day's Range   Trading Volume
19.97   -0.16 (0.79%)  19.80 - 20.32  1,679,900

Overview

 
Avg Volume (4 weeks):1,412,294
4 Weeks Range:17.53 - 20.50
4 Weeks Price Volatility (%):
82.15%
52 Weeks Range:14.61 - 20.50
52 Weeks Price Volatility (%):
91.00%
Average Price Target: 6.50
Price Target Upside/Downside: -13.47

Headlines



No recent Headlines for this stock.


Business Background

Halozyme Therapeutics is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme utilizes a strategy that focuses on developing its own proprietary products in therapeutic areas with significant unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

  Be the first to like this.
 


 

3414  4674  636  186 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 NIO 4.67+0.30 
 TTNP 0.334+0.084 
 SPY 331.95+1.03 
 SNCA 1.60+0.35 
 EEM 46.23+0.26 
 AVP 5.60-0.05 
 AMD 50.93+1.16 
 CHK 0.661-0.029 
 BAC 34.71-0.01 
 GE 11.81-0.03 
Partners & Brokers